Search results
Results From The WOW.Com Content Network
The ESPR is a not-for-profit organisation and aims to promote paediatric research and post-graduate training in Europe. It encourages collaboration between the various specialised fields of paediatrics, with the goal of maintaining paediatrics as a unified, scientifically-orientated discipline. The mission of the ESPR is to develop and apply ...
Esperion Therapeutics (ESPR) reports solid fourth-quarter results, beating estimates for earnings and sales. Stock surges. Esperion (ESPR) Q4 Earnings Beat, Product Sales Rise 49%
StockTwits. StockTwits is a social media platform designed for sharing ideas between investors, traders, and entrepreneurs. [1] The company was co-founded by Howard Lindzon and Soren Macbeth in 2009. The company received the first Shorty Award in the 2008 finance category. Time magazine listed the company as one of its 2010 "50 best websites."
Tuesday, Esperion Therapeutics (NASDAQ:ESPR) reported first-quarter revenues of $137.74 million, up 467% Y/Y, surpassing the consensus of $84.51 million. The company reported an EPS of $0.34, a ...
Esperion's (ESPR) stock rallies so far this year on higher product sales in the fourth quarter of 2021. Cost-saving initiatives to boost margins in 2022 are another key drivers.
Howard Lindzon is a Canadian Author, financial analyst, technical analyst and super angel investor. Lindzon manages a hedge fund, serves as managing partner of the holding company Social Leverage, limited partner at Knight's Bridge Capital Partners, and is the co-founder of StockTwits. Lindzon was named one of The Best Tweets for Your Money in ...
Esperion Therapeutics. Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 12.90% and 4.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the ...